Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule with the chemical formula C16H15F3N2O5S and a molecular weight of approximately 404.36 g/mol. It belongs to the class of organic compounds known as diphenylethers and contains both trifluoromethyl and sulfonamide functional groups. There are no approved indications or clinical trials reported for this compound; it is not approved in the US or elsewhere as a pharmaceutical agent. Its mechanism of action has not been described in public databases and there is no information on its biological targets or pharmacological activity[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-{[(4-phenoxyphenyl)sulfonyl]methyl}propanamide.